
Twenty-six patients with relapsed or drug-resistant cancer were treated with a combination of oral zzso zzso zzso zzso for 3 zzso and high-dose oral tamoxifen as a potential zzso of drug resistance zzso or zzso zzso zzso for 6 days beginning 3 days before zzso One patient with relapsed high-grade zzso and one with zzso of unknown primary site has a partial zzso zzso consisting of zzso vomiting and zzso zzso zzso of gait and malaise occurred during tamoxifen zzso zzso levels of tamoxifen averaged zzso zzso on day 4 of all courses of treatment at both zzso and zzso zzso zzso zzso levels were lower than tamoxifen during the first course (2 zzso but increased to equal tamoxifen levels during the second zzso zzso levels remained below 1 zzso In zzso both tamoxifen and the standard zzso of zzso resistance, zzso produced minor enhancement of zzso zzso in the zzso zzso cell line but produced no enhancement with any other cell zzso High, intermittent doses of tamoxifen can be given with acceptable toxicity and produce serum levels that have been shown to zzso drug resistance in zzso In zzso however, such levels have no significant effect on zzso zzso towards a range of zzso and zzso cell zzso 

